B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by B Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings
- Shares (Q2 2026)
- 70,000
- Value
- $6.21M
- % of portfolio
- 3.5%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 70,000 | $6.21M | 3.5% | −30,000−30.0% | Reduced | Holders |
| Q1 2026 | 100,000 | $5.04M | 3.7% | 00.0% | Unchanged | Holders |
| Q4 2025 | 100,000 | $3.28M | 2.4% | 00.0% | Unchanged | Holders |
| Q3 2025 | 100,000 | $1.68M | 1.6% | +20,000+25.0% | Added | Holders |
| Q2 2025 | 80,000 | $1.20M | 1.0% | +10,000+14.3% | Added | Holders |
| Q1 2025 | 70,000 | $1.13M | 1.0% | +20,000+40.0% | Added | Holders |
| Q4 2024 | 50,000 | $1.16M | 0.7% | – | No prior filing | Holders |